La bourse est fermée

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Prix différé. Devise en USD
Ajouter à la liste dynamique
365,02-3,44 (-0,93 %)
À la clôture : 04:00PM EDT
360,01 -5,01 (-1,37 %)
Échanges après Bourse : 04:38PM EDT

West Pharmaceutical Services, Inc.

530 Herman O. West Drive
Exton, PA 19341-1147
United States
610 594 2900
https://www.westpharma.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein10 600

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Eric M. GreenNon-Independent Chair of the Board, President & CEO2,9M45,4M1970
Mr. Silji AbrahamSenior VP & CTO972,09k4,64M1972
Ms. Kimberly Banks MacKaySenior VP, General Counsel & Company Secretary841,52kS.O.1966
Ms. Cindy Reiss-ClarkSenior VP & Chief Commercial Officer879,48k452,64k1974
Mr. Chad R. WintersVP, Chief Accounting Officer & Corporate ControllerS.O.S.O.1979
Michele PolinskyVice President of Global CommunicationsS.O.S.O.S.O.
Mr. Rudy PoussotSenior VP of Strategy & Corporate DevelopmentS.O.S.O.S.O.
Ms. Annette F. FavoriteChief Human Resources Officer & Senior VP803,25kS.O.1965
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Gouvernance d’entreprise

L’ISS Governance QualityScore de West Pharmaceutical Services, Inc. en date du 1 mai 2024 est 8. Les scores principaux sont Audit : 8; Société : 8; Droits des actionnaires : 8; Compensation : 4.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.